Iain Stuart
Vermögen: 76 632 $ am 31.05.2026
Vermögen: 76 632 $ am 31.05.2026
Dr. Iain A. Stuart is a Chief Scientific Officer at VYNE Therapeutics, Inc. Dr. Stuart was previously employed as a Chief Scientific Officer by Menlo Therapeutics, Inc., a Senior Vice President-Research & Development by VYNE Pharmaceuticals Ltd., a VP-Medical Strategy & Scientific Affairs by Leo Pharma, Inc., a Project Manager-Pharmaceutical Development by Bio Green Med Solution, Inc., and a Senior Director-Study by Inveresk Research Group, Inc. He received his undergraduate degree from Glasgow Caledonian University and a doctorate degree from Glasgow Caledonian University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 112’363 ( 0.34% ) | 76 632 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VYNE THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Corporate Officer/Principal | 01.01.2016 |
| VYNE THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| BIO GREEN MED SOLUTION, INC. | Corporate Officer/Principal | - |
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for dermatology, gynecology, wounds and burns and ophthalmic disorders | Health Technology |
Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Glasgow Caledonian University
Glasgow Caledonian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Retail Trade |
VYNE Therapeutics, Inc.
VYNE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen